The Effect of Mobile App-Based Interventions on Medication Adherence

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0010751

Enrollment

Registered

2025-07-11

Start date

2025-06-30

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Mobile App-Based Intervention) : The study adopts a pre-post time-lagged design with a control group, dividing participants with diabetes and hypertension into an experimental group and a contr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Individuals diagnosed with either essential (primary) hypertension or type 2 diabetes mellitus without complications , who have been taking oral medications for the condition within the past three years. 2) Aged 20 years or older. 3) Able to understand the content and purpose of this study. 4) Own a mobile device and have the ability to understand and use mobile applications. 5) Provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Individuals diagnosed with essential hypertension or type 2 diabetes mellitus who are receiving non-oral treatments, such as injectable antihypertensive drugs, insulin therapy, or dialysis. 2) Individuals undergoing treatment for complications related to the diagnosis, or those who are hospitalized due to diseases associated with essential hypertension or type 2 diabetes mellitus. 3) Individuals who are unable to communicate. 4) Minors (under the age of 20).

Design outcomes

Primary

Measure	Time frame
Individual Medication Adherence (Experimental Group/Control Group);Mobile Application Usage Information (Experimental Group);Diabetes Patients: Self-Monitored Fasting and Postprandial (2-Hour) Blood Glucose Data - Hypertension Patients: Blood Pressure Measurement Data (Experimental Group/Control Group);Diabetes Patients: HbA1c Results from Hospital Visits, Blood Glucose Measurement Results - Hypertension Patients: Blood Pressure Measurement Results from Hospital Visits (Experimental Group/Control Group)	—

Measure

Time frame

Individual Medication Adherence (Experimental Group/Control Group);Mobile Application Usage Information (Experimental Group);Diabetes Patients: Self-Monitored Fasting and Postprandial (2-Hour) Blood Glucose Data - Hypertension Patients: Blood Pressure Measurement Data (Experimental Group/Control Group);Diabetes Patients: HbA1c Results from Hospital Visits, Blood Glucose Measurement Results - Hypertension Patients: Blood Pressure Measurement Results from Hospital Visits (Experimental Group/Control Group)

—

Secondary

Measure	Time frame
Questionnaires - General characteristics of participants (intervention group/control group);Questionnaires - Self-Efficacy for Appropriate Medication Use Scale (SEAMS) (intervention group/control group);Questionnaires - Self-Reported Behavioral Automaticity Index (SRBAI) (intervention group/control group)	—

Countries

Korea, Republic of

Contacts

Public ContactSuhee Moon

Mokpo National University

001artemis@naver.com+82-61-450-6292

Outcome results